Febuxot 40mg Tablet contains Febuxostat, a xanthine oxidase inhibitor used primarily to manage hyperuricemia in patients with gout. By selectively inhibiting the enzyme xanthine oxidase, Febuxostat reduces the production of uric acid, thereby lowering serum urate levels and preventing gout attacks and complications such as tophi formation. This medication is typically prescribed for adults who have not responded adequately to other urate-lowering therapies or who are intolerant to allopurinol. Febuxot 40mg is usually taken once daily, with or without food, and dosage adjustments may be necessary based on renal function and clinical response. Common side effects include liver function abnormalities, nausea, rash, and joint pain, while serious adverse effects are rare but may include cardiovascular events; therefore, patients with a history of heart disease should use Febuxot cautiously under medical supervision. Regular monitoring of liver enzymes and serum uric acid levels is recommended during treatment. Febuxot should not be used in patients with severe liver impairment or hypersensitivity to Febuxostat. It is important to maintain adequate hydration and avoid alcohol consumption to enhance treatment efficacy and reduce the risk of adverse effects. Always consult a healthcare professional before starting or discontinuing this medication.